Development of improved nomogram for prediction of outcome of initial prostate biopsy using readily available clinical information

Urology

Volumn 78, Issue 2, 2011, Pages 392-398

  Zaytoun, Osama M ^a   Kattan, Michael W ^a   Moussa, Ayman S ^a   Li, Jianbo ^a   Yu, Changhong ^a   Jones, J Stephen ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CALIBRATION; CANCER DIAGNOSIS; CANCER RISK; DIGITAL RECTAL EXAMINATION; FAMILY HISTORY; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; NOMOGRAM; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; RACE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; HUMANS; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATE; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT;

EID: 80051470702     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2011.04.042     Document Type: Article

References (30)

1. T.A. Stamey, N. Yang, and A.R. Hay Prostate specific antigen as a serum marker for adenocarcinoma of the prostate N Engl J Med 317 1987 909 916 (Pubitemid 17147932)
2. W.H. Cooner, B.R. Mosley, and C.J. Rutherford Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen J Urol 167 1990 966 973 2002
3. W.J. Catalona, D.S. Smith, and T.L. Ratliff Measurement of prostate specific antigen in serum as a screening test for prostate cancer N Engl J Med 324 1991 1156 1161
4. S. Kawakami, K. Kihara, and Y. Fujii Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer Int J Urol 11 2004 613 618 (Pubitemid 39128562)
5. S. Kawakami, N. Hyochi, and J. Yonese Three-dimensional combination of transrectal and transperineal biopsies for efficient detection of stage T1c prostate cancer Int J Clin Oncol 11 2006 127 132
6. V. Scattoni, A. Zlotta, and R. Montironi Extended and saturation prostatic biopsy in the diagnosis and characterisation of prostate cancer: a critical analysis of the literature Eur Urol 52 2007 1309 1322 (Pubitemid 47446019)
7. M. Garzotto, R.G. Hudson, and L. Peters Predictive modeling for the presence of prostate carcinoma using clinical, laboratory and ultrasound parameters in patients with prostate specific antigen levels ≤10 ng/mL Cancer 98 2003 1417 1422 (Pubitemid 37151496)
8. M. Graefen, P.I. Karakiewicz, and I. Cagiannos International validation of preoperative nomogram for prostate cancer recurrence after radical prostatectomy J Clin Oncol 20 2002 3206 3212 (Pubitemid 34831516)
9. M.W. Kattan, J.A. Eastham, and T.M. Wheeler Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors J Urol 170 2003 1792 1797 (Pubitemid 37254930)
10. J.A. Eastham, R. May, and J.L. Robertson Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL Urology 54 1999 709 713 (Pubitemid 29449435)
11. B.V. Yanke, B.S. Carver, and F.J. Bianco Jr African-American race is a predictor of prostate cancer detection: incorporation into a pre-biopsy nomogram BJU Int 98 2006 783 787 (Pubitemid 44368025)
12. F.K. Chun, A. Briganti, and M. Graefen Development and external validation of an extended 10-core biopsy nomogram Eur Urol 52 2007 436 444
13. F. Schröder, and M.W. Kattan The comparability of models for predicting the risk of a positive prostate biopsy with prostate-specific antigen alone: a systematic review Eur Urol 54 2008 241 242
14. B. Djavan, M. Remzi, and A. Zlotta Novel artificial neural network for early detection of prostate cancer J Clin Oncol 20 2002 921 929 (Pubitemid 34141833)
15. M. Ramirez-Backhaus, P. Bahilo, and S. Arlandis Prospective validation of a nomogram predictive of a positive initial prostate biopsy Actas Urol Esp 34 2010 35 42
16. R.K. Nam, A. Toi, and L.H. Klotz Assessing individual risk for prostate cancer J Clin Oncol 25 2007 3582 3588 (Pubitemid 47372595)
17. P.I. Karakiewicz, S. Benayoun, and M.W. Kattan Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen J Urol 173 2005 1930 1934 (Pubitemid 40675214)
18. S.A. Optenberg, J.Y. Clark, and M.K. Brawer Development of a decision-making tool to predict risk of prostate cancer: the Cancer of the Prostate Risk Index (CAPRI) test Urology 50 1997 665 672 (Pubitemid 27494983)
19. G.D. Carlson, C.B. Calvanese, and A.W. Partin An algorithm combining age, total prostate- specific antigen (PSA) and percent free PSA to predict prostate cancer: results on 4298 cases Urology 52 1998 455 461 (Pubitemid 28399914)
20. P.C. Albertsen, D.G. Fryback, and B.E. Storer Long-term survival among men with conservatively treated localized prostate cancer JAMA 274 1995 626 631
21. W.J. Catalona Management of cancer of the prostate N Engl J Med 331 1994 996 1004
22. I.M. Thompson, D.P. Ankerst, and C. Chi Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 2006 529 534 (Pubitemid 43898816)
23. W.J. Catalona, D.S. Smith, and R.L. Wolfert Evaluation of percentage of free serum prostate specific antigen to improve specificity of prostate cancer screening Am J Med 274 1995 1214 1220
24. C.T. Nguyen, C. Yu, and A.S. Moussa The Prostate Cancer Prevention Trial Risk calculator does not perform well in a contemporary cohort of men screened for prostate cancer with extended prostate biopsy schemes J Urol 183 2010 529 533
25. B.V. Yanke, M. Gonen, and P.T. Scardino Validation of a nomogram for predicting positive repeat biopsy for prostate cancer J Urol 173 2005 421 424
26. A.S. Moussa, J.S. Jones, and C. Yu Development and validation of a nomogram for predicting a positive repeat prostate biopsy in patients with a previous negative biopsy session in the era of extended prostate sampling BJU Int 106 2010 1309 1314
27. T. Utsumi, K. Kawamura, and H. Suzuki External validation and head-to-head comparison of Japanese and Western prostate biopsy nomograms using Japanese data sets Int J Urol 16 2009 416 419
28. F. Dong, M.W. Kattan, and E.W. Steyerberg Validation of pretreatment nomograms for predicting indolent prostate cancer: efficacy in contemporary urological practice J Urol 180 2008 150 154
29. J.B. Yu, D.V. Makarov, and R. Sharma Validation of the Partin nomogram for prostate cancer in a national sample J Urol 183 2010 105 111
30. M.W. Kattan Factors affecting the accuracy of prediction models limit the comparison of rival prediction models when applied to separate data sets Eur Urol 59 2011 566 567